Cancer Treatment Denied in India: How to Appeal

India faces a mounting cancer burden — over 1.4 million new cases are diagnosed each year — and the costs of cancer treatment, especially with newer targeted therapies and immunotherapies, can rapidly exhaust family savings. Health insurance should provide a safety net, but cancer-related insurance denials are among the most common complaints filed with India's insurance regulators. Here is how to understand your coverage and fight back if denied.

How Cancer Treatment Is Covered in India

Ayushman Bharat – PMJAY: The PMJAY scheme provides coverage of up to ₹5 lakh per family per year at empanelled public and private hospitals. Cancer treatment is included in the Health Benefits Packages (HBPs). Covered services include:

• Cancer surgery (mastectomy, colectomy, hysterectomy for cancer, etc.)
• Chemotherapy courses (inpatient administration)
• Radiotherapy
• Stem cell transplantation for certain haematological cancers
• Diagnostic procedures (biopsies, PET scans where included)

PMJAY does not cover outpatient oral chemotherapy tablets or most newer targeted therapy drugs administered in ambulatory settings, which is a significant coverage gap for patients on modern regimens.

State-level cancer programs: Many states have supplementary cancer treatment schemes. Tamil Nadu's Chief Minister's Comprehensive Health Insurance Scheme, Andhra Pradesh's Dr YSR Aarogyasri, and Maharashtra's Mahatma Jyotiba Phule Jan Arogya Yojana all include cancer-related benefits. Coverage varies significantly by state and by the specific HBP list.

Private health insurance: Standard comprehensive health insurance policies in India typically cover hospitalisation for cancer treatment — surgery, inpatient chemotherapy, and radiotherapy. However, cancer coverage is heavily affected by:

• Pre-existing disease (PED) waiting periods
• Sub-limits for specified illnesses
• Cancer-specific waiting periods in some policies
• Exclusions for experimental or non-standard treatments

Critical illness and cancer-specific policies: Some policyholders have separate critical illness policies or cancer-specific insurance that pays a lump sum on diagnosis of cancer meeting defined criteria. These policies carry their own definitional requirements (e.g., Stage II or above, specific cancer types) and are a common source of disputes.

Common Reasons Cancer Claims Are Denied in India

• Pre-existing disease exclusion: The insurer argues that cancer symptoms predated the policy or that the cancer was a pre-existing condition within the waiting period.
• Non-disclosure at proposal: If cancer or symptoms were not disclosed when the policy was taken out, the insurer may repudiate the policy entirely.
• Waiting period for cancer: Some policies have a specific 30-day or 90-day initial waiting period during which no cancer claims are payable.
• Critical illness policy stage requirement not met: Cancer-specific policies may only pay for Stage III or Stage IV cancer, denying claims for earlier-stage diagnoses.
• Treatment not at empanelled hospital (PMJAY): PMJAY benefits only apply at hospitals on the PMJAY empanelment list.
• Oral targeted therapy excluded: Modern targeted cancer drugs (e.g., imatinib for CML, erlotinib for NSCLC) administered as oral tablets are classified as outpatient/OPD and excluded from hospitalisation-only policies.

How to Appeal a Cancer Insurance Denial in India

Step 1 — File a formal grievance with your insurer's GRO: Every insurer must have a Grievance Redressal Officer under IRDAI regulations. Submit a written grievance citing the relevant policy clause, your oncologist's clinical report, and any IRDAI circulars relevant to your situation. The insurer must respond within 15 days.

Step 2 — Escalate to IRDAI Bima Bharosa portal: If unresolved, file through bimabharosa.irdai.gov.in or call the IRDAI consumer helpline at 155255. IRDAI can direct insurers to settle legitimate claims and investigates systemic non-compliance.

Step 3 — Insurance Ombudsman: Approach the regional Insurance Ombudsman for disputes up to ₹50 lakh. For cancer treatment disputes — which frequently involve high-cost claims — this is an important forum. The Ombudsman process is free, relatively quick, and decisions are binding on insurers. File at cioins.co.in.

Step 4 — Consumer Forum / NCDRC: For larger disputes or if you are dissatisfied with the Ombudsman decision, the consumer protection framework (District Forum, State Commission, NCDRC) under the Consumer Protection Act 2019 offers a further avenue. No court fee is required for relatively small disputes.

IRDAI Rules on Cancer Pre-Existing Conditions

IRDAI's 2024 Health Insurance Regulations cap PED waiting periods at 3 years, with many standard waiting periods being 2 years. Importantly, IRDAI also requires that insurers inform policyholders clearly of PED provisions at policy issuance. If you were not adequately informed, or if the insurer is applying a PED waiting period beyond the regulatory maximum, you have a strong regulatory ground for your complaint.

Key Organisations

Indian Cancer Society (ICS) (indiancancersociety.org) runs a helpline and provides patient support, financial assistance for treatment, and advocacy resources for individuals navigating insurance denials.

Tata Memorial Centre patient welfare offices and state-run cancer hospitals often have medical social workers who can assist with PMJAY empanelment queries and insurance navigation.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal